ÍøºìºÚÁÏ

Skip to main content

Jonathan D Licht, MD

Cancer Specialist (Oncologist), Hematology and Oncology Specialist

Photo of Jonathan D Licht

Research at a glance

Top areas of exploration

  • Transcription Factors , 58 publications
  • DNA-Binding Proteins , 55 publications
  • Gene Expression Regulation, Neoplastic , 38 publications
  • Transcription, Genetic , 38 publications

Research activity

239 publications

23,383 citations

Why is this important?

My publications

239 publications

2014

From anecdote to targeted therapy: the curious case of thalidomide in multiple myeloma.

Cancer cell

•

2014

Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.

PLoS genetics

•

2014

Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination.

Clinical cancer research : an official journal of the American Association for Cancer Research

•

2014

Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.

Leukemia

•

2014

Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.

The Journal of biological chemistry

•